Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

pengarang

Caterina Costa

Simona De Summa

Enrico Bucci

1972 -

Luciano Mutti

Francesca Pentimalli

1973 -

Antonio Giordano

1962 -

Iris Maria Forte

Carmelina Antonella Iannuzzi

Paola Indovina

Eliseo Mattioli

Luca Luzzi

Cristiana Bellan

Marisa De Feo

diterbitkan dalam: Cell Death and Disease

tanggal publikasi: 2020-09-14

Cites articles 69

Date

Judul

Pengarang

2020-04-24

Prognostic and clinicopathological utility of programmed death-ligand 1 in malignant pleural mesothelioma: A meta-analysis
2020-02-21

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

Robin Tranchant, Didier Jean
2019-09-12

ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a
2019-09-11

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
2019-07-08

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Michele Carbone, Fabrizio Bardelli, Emanuela Felley-Bosco, Françoise Galateau-Salle, Harvey I Pass, Marjorie Zauderer, H. Richard Alexander, Valerie W Rusch, Emanuela Taioli
2019-01-01

LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

Ziwen Zhao
2018

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
2018-10-15

Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine

Alan D D'Andrea, Wei Jia, Harvey I Pass, Paolo Pinton, Saïd M Sebti, Carol Prives
2018

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

Peixin Dong, Sharon J B Hanley, Hidemichi Watari, Junming Yue
2018-09-12

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Frank Bray
2018-09-01

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

Luciano Mutti, Fred R Hirsch, Bruce W. Robinson
2018-05-24

MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway
2018-08

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

Ming-Sound Tsao, Nolwenn Le Stang, Mary Beth Beasley
2018-02-06

Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma

Jean-Michel Maury, Marie Brevet, Lara Chalabreysse
2018-01-01

Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved.
2018-02-17

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
2018-01-01

Reviewing the future of the P53 field
2017-12-30

Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients

Xin Lai, Julio Vera
2017-10-19

miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer
2017-11-10

Updates from the TP53 universe.

Francesca Pentimalli
2017-08-24

Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma

Bahareh Badrian
2017-11-18

A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma

Michaela B. Kirschner, Karin Schelch, Michael Grusch, Glen Reid, Marissa Williams, Nico van Zandwijk
2017-06-16

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Michaela B. Kirschner, Nico van Zandwijk, Richard Scolyer, Michael J. Boyer, Glen Reid, Marissa Williams, Yuen Yee Cheng, Brian C McCaughan, Sonja Klebe, Kadir H Sarun
2017-03-14

MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor
2017-05-13

miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
2017-03-06

MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma
2017-02-01

miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients
2017-01-28

Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics

George A. Calin
2016-12-30

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong-Yi Dong
2016-12-15

MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma
2016-12-19

Non-coding RNAs: the cancer genome dark matter that matters!

Leonard Girnita, George A. Calin
2016-11-14

Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.

Shohei Koyama, Pasi A Jänne, Patrick H Lizotte, David A Barbie, F Stephen Hodi

Artikel - wd:Q99417873

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut